Clinical Trial Update: Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

View source ↗

Summary

This update notes termination of a clinical trial evaluating an immunologic diagnostic blood test intended to predict donor stem cell transplant-related side ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• Neuroblastoma
• Therapy-related Toxicity

Snippet

Sponsor: City of Hope Medical Center | Conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease | Status: TERMINATED